Objectives To test the feasibility of a new device for gasless laparoscopy in providing working space for diaphragmatic hernia repair in an ex vivo canine model as a pre‐clinical study. Study design Technical feasibility study. Animal Eight beagles and two greyhound cadavers (not client‐owned). Methods The new device was used for abdominal traction in gasless laparoscopic reconstruction of diaphragmatic hernias produced in dog cadavers. It consists of three main parts (vertical and horizontal rods, a three‐piece structure, and a 3D‐printed unit that incorporates slots for haemostatic forceps). Composite hernias (two incisions of about 4 cm) were closed by an intra‐corporeal suture [suture group (GS), n = 5] or by a central suture and a polypropylene mesh [mesh group (GM), n = 5]. Surgical steps were T1 (primary port access up to third port placement), T2 (defect development), and T3 (diaphragmatic reconstruction). Total surgical time (TT) was also recorded. Results The defect was successfully developed and reconstructed in all cadavers. To close the defect, 7.0 ± 0.7 crossed mattress sutures were required in the GS, and 15.2 ± 1.9 hernia staples and one intra‐corporal suture were used in the GM. T3 was longer (p = 0.0076) in GS (50.00 ± 16.46 min) than in GM (23.24 ± 5.25 min). TT was 87.22 ± 19.23 min in GS and 66.45 ± 6.38 min in GM (p = 0.0547). Conclusions Gasless laparoscopic diaphragmatic hernia repair using the developed device is feasible in the canine cadaver model. Both suture and mesh graft techniques for experimental diaphragmatic herniorrhaphy can be performed using this new device in this pre‐clinical model. Clinical significance This new device for gasless laparoscopy allows diaphragmatic herniorrhaphy by intra‐corporeal suture or mesh implantation in ex vivo canine model. The device demonstrates potential for future use in clinical cases.

Insulin like growth factor‐1 (IGF‐1) plays an important role in the regulation of ovarian function. Despite its extensive study in several species, there is a paucity of information about IGF‐1`s function and localization in the canine ovary. The aim of the present study was to assess the effect of IGF‐1 on oocyte nuclear maturation and to immunolocalize the IGF‐1 and its receptor (IGF‐1R) in the ovary. Cumulus‐oocyte complexes (COCs) were obtained from 34 bitches. The COCs from each bitch were incubated in TCM 199‐HEPES in the absence (n = 199) or presence (n = 204) of 100 ng/ml IGF‐1 for 96 hr at 38ºC in 5% CO2, stained and evaluated for nuclear maturation by fluorescence microscopy. The results showed that the addition of IGF‐1 did not have an effect (p ˃ 0.05) on the nuclear maturation under these conditions. The immunohistochemical study revealed nuclear and cytoplasmic staining for IGF‐1 and IGF‐1R, respectively. Both were localized in all ovarian structures including the corpus luteum, but not in the granulosa cells from primordial follicles. In addition, IGF‐1 was not localized in the oocytes in tertiary follicles. The results obtained show the presence of IGF‐1 through the stages of follicular growth and in the corpus luteum of the canine ovary. However, its role on oocyte nuclear maturation could not be demonstrated.

No abstract

No abstract

No abstract